MA
FBRX icon

MYDA Advisors’s Forte Biosciences FBRX Stock Holding History

MYDA Advisors’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-800
Closed -$672K – 279
2021
Q2 		$672K Sell
800
-320
-29% -$288K 0.17% 158
2021
Q1 		$960K Hold
1,120
– – 0.27% 119
2020
Q4 		$1.02M Sell
1,120
-240
-18% -$226K 0.3% 83
2020
Q3 		$1.65M Sell
1,360
-240
-15% -$159K 0.86% 33
2020
Q2 		$583K Buy
1,600
+1,152
+257% +$515K 0.35% 58
2020
Q1 		$205K Buy
+448
New +$175K 0.13% 105

Other funds holding FBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
OQS
Occudo Quantitative Strategies Fort Lauderdale, Florida $1.88B AUM 35.68% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

MYDA Advisors's FBRX Position: Q3 2021 in Review

MYDA Advisors sold out of Forte Biosciences (FBRX) in Q3 2021, closing a stake of 800 shares — an estimated $672K sold.

MYDA Advisors first reported a position in FBRX in Q1 2020 and held it in 6 quarters. The position peaked at $1.65M in Q3 2020. 57 funds tracked by Wall St. Rank hold FBRX as of Q3 2021.

  • MYDA Advisors reported no remaining Forte Biosciences position as of Q3 2021 after selling out during the quarter.
  • MYDA Advisors sold 800 Forte Biosciences shares in Q3 2021, an estimated $672K.
  • MYDA Advisors first reported a position in Forte Biosciences in Q1 2020 and held it in 6 quarters.
  • MYDA Advisors's Forte Biosciences position peaked at $1.65M in Q3 2020.
  • 57 funds tracked by Wall St. Rank held Forte Biosciences as of Q3 2021.

Based on MYDA Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.